Iressa/Docetaxel in Non-Small-Cell Lung Cancer

This study has been withdrawn prior to enrollment.

(Slow accrual.)

Sponsor:

Collaborators:

AstraZeneca

Aventis Pharmaceuticals

Information provided by (Responsible Party):

M.D. Anderson Cancer Center

ClinicalTrials.gov Identifier:

NCT00048087

First received: October 24, 2002

Last updated: July 27, 2012

Last verified: July 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Study Completion Date:	July 2003
Primary Completion Date:	July 2003 (Final data collection date for primary outcome measure)